Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (31-40 of 291) with videos related to

Pageof 30
Sort By:
Cell|April 15, 2014
Peering into the crystal ball: influenza pandemics and vaccine efficacyMatthew S Miller, Peter Palese
Antiviral Research|March 14, 2017
Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza virusesVictor H Leyva-Grado, Peter Palese
Current Topics in Microbiology and Immunology|July 11, 2014
Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutininFlorian Krammer, Peter Palese, John Steel
Journal of Virology|November 8, 2019
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and ImmunocytokinesGayathri Vijayakumar, Stephen McCroskery, Peter Palese
Journal of Virology|April 8, 2011
Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cellsMena Mansour, Peter Palese, Dmitriy Zamarin
Current Topics in Microbiology and Immunology|September 22, 2009
Recombinant vectors as influenza vaccinesSarah A Kopecky-Bromberg, Peter Palese
Journal of Visualized Experiments : Jove|December 5, 2013
Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression systemIrina Margine, Peter Palese, Florian Krammer
Cold Spring Harbor Perspectives in Biology|July 1, 2017
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza VaccineFlorian Krammer, Adolfo García-Sastre, Peter Palese
Journal of Virology|July 13, 2012
A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomesPeter H Goff, Qinshan Gao, Peter Palese
Journal of Virology|October 25, 2013
Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domainDirk Eggink, Peter H Goff, Peter Palese
Pageof 30

Showing results (31-40 of 291) with videos related to

Sort By:
Pageof 30
Cell|April 15, 2014
Peering into the crystal ball: influenza pandemics and vaccine efficacyMatthew S Miller, Peter Palese
Antiviral Research|March 14, 2017
Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza virusesVictor H Leyva-Grado, Peter Palese
Current Topics in Microbiology and Immunology|July 11, 2014
Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutininFlorian Krammer, Peter Palese, John Steel
Journal of Virology|November 8, 2019
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and ImmunocytokinesGayathri Vijayakumar, Stephen McCroskery, Peter Palese
Journal of Virology|April 8, 2011
Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cellsMena Mansour, Peter Palese, Dmitriy Zamarin
Current Topics in Microbiology and Immunology|September 22, 2009
Recombinant vectors as influenza vaccinesSarah A Kopecky-Bromberg, Peter Palese
Journal of Visualized Experiments : Jove|December 5, 2013
Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression systemIrina Margine, Peter Palese, Florian Krammer
Cold Spring Harbor Perspectives in Biology|July 1, 2017
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza VaccineFlorian Krammer, Adolfo García-Sastre, Peter Palese
Journal of Virology|July 13, 2012
A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomesPeter H Goff, Qinshan Gao, Peter Palese
Journal of Virology|October 25, 2013
Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domainDirk Eggink, Peter H Goff, Peter Palese
Pageof 30